Bond, C., Blenkinsopp, A. and Raynor, D. K. (2012). Prescribing and partnership with patients. British journal of clinical pharmacology. Oct 1;74(4):581-8. DOI: 10.1111/j.1365-2125.2012.04330.
Hughes, L. (2014). Shared decision making in antipsychotic prescribing. National Elf Service.
Morant, N., Azam, K., Johnson, S. and Moncrieff, J. (2017). The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample. Journal of Mental Health. Aug 30:1-7. DOI:10.1080/09638237.2017.1370637.
Morrison, A. P., Hutton, P., Shiers, D. and Turkington, D. (2012). Antipsychotics: is it time to introduce patient choice? The British Journal of Psychiatry. August 201(2): 83-84. DOI: 10.1192/bjp.bp.112.112110.
Murray, R. M., Quattrone, D., Natesan, S., van Os, J., Nordentoft, M., Howes, O., Di Forti, M. and Taylor D. Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics? The British Journal of Psychiatry. Nov 1;209(5):361-5. DOI: 10.1192/bjp.bp.116.182683.
National Association of State Mental Health Program Directors. Optimising Medication Management for Persons who experience first episode psychosis Substance. Cited January 2018. This brochure contains the link to: An Option Grid for medication choices for people who experience a first episode psychosis.
Ness, O., Borg, M., Semb, R. and Karlsson, B. (2014). Walking alongside: collaborative practices in mental health and substance use care. International journal of mental health systems. Dec 17;8(1):55.
Younas, M., Bradley, E., Holmes, N., Sud, D. and Maidment, I. D. (2016). Mental health pharmacists’ views on shared decision-making for antipsychotics in serious mental illness. International journal of clinical pharmacy. Oct 1;38(5):1191-9. DOI: 10.1007/s11096-016-0352-z.